Mayo Clinic
Subject: Smoking and Health Research Foundation of Australia
Abstract
Reports that the "SRRC met and recommended that Philip Morris pursue the second strategy option" described in a previous memo. Defines the "second strategy option" only as "most consistent with current trends and tactics both within and outside the industry." Suggests that due to pending disbandment, neither the Tobacco Institute nor CTR would be "good sources of assistance." Expresses interest in discussing "the worldwide situation regarding these issues" with a Professor Bernard, but predicts little benefit.
Fields
- Type
- Telex
- Memorandum
- Company
- Philip Morris
- Site
- MN Depository
- Author
- Ellis, Cathy Lynn, Ph.D. (PM VP of Worldwide Scientific Affairs)Director of Research at Philip Morris U.S.A. in 1994. In 1997 was Senior VP of R&D at PM (2505370877). Osdene protégé.
- Recipient
- Goldberg, Henry (Philip Morris (Australia) Limited)Managing Director, Philip Morris (Australia) Limited, Australia
1998 Hong Kong. Member of PM Ventilation Task Force. Member of ARTIST.
Philip Morris Director and worked in Scientific Affairs. Reported to Cathy ellis.
Joined PM in June '75 and worked as a Research Scientist until Mar. '97 appt
1997 Scientific Research Review Committee - PM's committee to review and approve external and internal research proposals. Created in 1997. Reviews proposals for INBIFO, CIAR (prior to disbandment), and VDC are included in responsibility.
Philip Morris & Co. Ltd.., was incorporated in New York in April of 1902; half the shares were held by the parent company in London, and the balance by its U.S. distributor and his American associate. Its overall sales in 1903, its first full year of U.S. operation, were a modest seven million cigarettes. Among the brand offered, besides Philip Morris, were Blues, Cambridge, Derby, and a ladies favorite name for the London street where the home companies factory was located - Marlborough.
The purpose of the Institute was to defeat legislation unfavorable to the industry, put a positive spin on the tobacco industry, bolster the industry's credibility with legislators and the public, and help maintain the controversy over "the primary issue" (the health issue).
Created and funded by the tobacco industry to award grants to study of the link between smoking and disease. Part of a four decade effort to cast doubt on the links between smoking and disease.
No images found for document.